These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6761340)

  • 1. Insulin control of a transplasma membrane NADH dehydrogenase in erythrocyte membranes.
    Crane FL; Crane HE; Sun IL; MacKellar WC; Grebing C; Löw H
    J Bioenerg Biomembr; 1982 Dec; 14(5-6):425-33. PubMed ID: 6761340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transmembranous NADH-dehydrogenase in human erythrocyte membranes.
    Grebing C; Crane FL; Löw H; Hall K
    J Bioenerg Biomembr; 1984 Dec; 16(5-6):517-33. PubMed ID: 6537435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of extracellular potassium ferricyanide by transmembrane NADH: (acceptor) oxidoreductase of human erythrocytes.
    Schipfer W; Neophytou B; Trobisch R; Groiss O; Goldenberg H
    Int J Biochem; 1985; 17(7):819-23. PubMed ID: 4054423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the existence of two NADH-ferricyanide reductases in human erythrocyte membranes [proceedings].
    Agutter PS; Dallas JM; Newman P; Kadlubowski M
    Biochem Soc Trans; 1980 Jun; 8(3):326. PubMed ID: 7399071
    [No Abstract]   [Full Text] [Related]  

  • 5. An assessment of the value of the crypticity of NADH-ferricyanide reductase as an indicator of structural integrity of human erythrocyte membranes [proceedings].
    Stewart CA; Agutter PS; Kadlubowski M
    Biochem Soc Trans; 1980 Jun; 8(3):325. PubMed ID: 7399070
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification and properties of human erythrocyte membrane NADH-cytochrome b5 reductase.
    Kitajima S; Yasukochi Y; Minakami S
    Arch Biochem Biophys; 1981 Aug; 210(1):330-9. PubMed ID: 7294831
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma membrane nadh dehydrogenase and Ca2+-dependent potassium transport in erythrocytes of several animal species.
    Miner C; López-Burillo S; García-Sancho J; Herreros B
    Biochim Biophys Acta; 1983 Jan; 727(2):266-72. PubMed ID: 6404302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects.
    Choury D; Leroux A; Kaplan JC
    J Clin Invest; 1981 Jan; 67(1):149-55. PubMed ID: 7451647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological similarity between NADH-cytochrome b5 reductase of erythrocytes and liver microsomes.
    Goto-Tamura R; Takesue Y; Takesue S
    Biochim Biophys Acta; 1976 Feb; 423(2):293-302. PubMed ID: 2319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for endogenous proteolytic solubilization of human red-cell membrane NADH-cytochrome b5 reductase.
    Choury D; Wajcman H; Boissel JP; Kaplan JC
    FEBS Lett; 1981 Apr; 126(2):172-4. PubMed ID: 7016586
    [No Abstract]   [Full Text] [Related]  

  • 11. Transplasmalemma NADH dehydrogenase is inhibited by actinomycin D.
    Sun IL; Crane FL
    Biochem Biophys Res Commun; 1981 Jul; 101(1):68-75. PubMed ID: 7284008
    [No Abstract]   [Full Text] [Related]  

  • 12. Ascorbate-dependent electron transfer across the human erythrocyte membrane.
    May JM; Qu ZC
    Biochim Biophys Acta; 1999 Sep; 1421(1):19-31. PubMed ID: 10561468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of a NADH dehydrogenase in the human erythrocyte by beta-adrenergic agonists: possible involvement of a G protein in enzyme activation.
    Marques F; Bicho MP
    Biol Signals; 1997; 6(2):52-61. PubMed ID: 9266092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of domain-specific erythrocyte membrane modulators on acetylcholinesterase and NADH:cytochrome b5 reductase activities.
    Palmieri DA; Rangachari A; Butterfield DA
    Arch Biochem Biophys; 1990 Jul; 280(1):224-8. PubMed ID: 2162152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of pyridine nucleotide oxidizing enzymes from human neutrophils.
    Mackler B; Person R; Davis KA; Ochs H
    Biochem Int; 1985 Sep; 11(3):319-25. PubMed ID: 3933511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of erythrocyte plasma membrane NADH dehydrogenase by nucleotides and uncouplers.
    Howland JL; Osrin D; Donatelli M; Theofrastous JP
    Biochim Biophys Acta; 1984 Dec; 778(3):400-4. PubMed ID: 6509043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recycling of the ascorbate free radical by human erythrocyte membranes.
    May JM; Qu Z; Cobb CE
    Free Radic Biol Med; 2001 Jul; 31(1):117-24. PubMed ID: 11425497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NADH/NADPH-methemoglobin reduction system or erythrocytes.
    Hultquist DE; Sannes LJ; Schafer DA
    Prog Clin Biol Res; 1981; 55():291-309. PubMed ID: 7027268
    [No Abstract]   [Full Text] [Related]  

  • 19. Decrease of NADH in HeLa cells in the presence of transferrin or ferricyanide.
    Navas P; Sun IL; Morré DJ; Crane FL
    Biochem Biophys Res Commun; 1986 Feb; 135(1):110-5. PubMed ID: 3954760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human NADH-cytochrome b5 reductases: comparison among those of erythrocyte membrane, erythrocyte cytosol, and liver microsomes.
    Kitajima S; Minakami S
    J Biochem; 1983 Feb; 93(2):615-20. PubMed ID: 6841358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.